Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010110
Filing Date
2025-05-14
Accepted
2025-05-14 09:00:37
Documents
45
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 305269
2 EX-31.1 ex31-1.htm EX-31.1 12319
3 EX-31.2 ex31-2.htm EX-31.2 9157
4 EX-32.1 ex32-1.htm EX-32.1 4654
5 EX-32.2 ex32-2.htm EX-32.2 4771
  Complete submission text file 0001641172-25-010110.txt   2018543

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inti-20250331.xsd EX-101.SCH 17172
7 XBRL CALCULATION FILE inti-20250331_cal.xml EX-101.CAL 28908
8 XBRL DEFINITION FILE inti-20250331_def.xml EX-101.DEF 57500
9 XBRL LABEL FILE inti-20250331_lab.xml EX-101.LAB 145755
10 XBRL PRESENTATION FILE inti-20250331_pre.xml EX-101.PRE 115673
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 175115
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 25942974
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)